| Literature DB >> 33262653 |
Bo Lian1, Jie Chen1, Zhengyan Li1, Gang Ji1, Shiqi Wang1, Qingchuan Zhao1, Mengbin Li1.
Abstract
BACKGROUND: Laparoscopy has been increasingly used for the surgery of gastric cancer. However, the postoperative complications are still under-investigated and the short-term results of laparoscopic gastrectomy remain controversial. This study aimed to explore the differences of postoperative complications between laparoscopic and open radical gastrectomies in patients with gastric cancer through the large sample size, retrospective cohort study, and evaluate the safety of laparoscopy in patients who underwent radical gastrectomy. PATIENTS AND METHODS: A total of 2,966 patients with gastric cancer (TNM I~III) who underwent laparoscopy or open gastrectomy from February 2009 to March 2016 were enrolled in this study. Complications were categorized according to the Clavien-Dindo classification. The incidence and severity of complications between laparoscopic and open gastrectomy were compared using one-to-three propensity score matching (PSM) analysis. Logistic regression analyses were performed to identify risk factors related to postoperative complications.Entities:
Keywords: Clavien–Dindo classification; gastric cancer; gastric resection; laparoscopy; postoperative complication
Year: 2020 PMID: 33262653 PMCID: PMC7700075 DOI: 10.2147/CMAR.S275621
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
The Demographic Characteristics of the Patients
| Before PSM | After PSM | |||||||
|---|---|---|---|---|---|---|---|---|
| Entire, n=2,966 (100) | LG, n= 687 (23.2) | OG, n=2,279 (76.8) | Entire 2373(100) | LG 676(28.5) | OG 1697(71.5) | |||
| Age (years) (mean±SD) | 57.4±9.8 | 57.1±9.5 | 57.5±9.8 | 0.412 | 57.2±9.7 | 57.2±9.5 | 57.2±9.8 | 0.981 |
| Gender | 0.193 | 0.820 | ||||||
| Male | 2,241 (75.6) | 532 (77.4) | 1,709 (75.0) | 1,825 (76.9) | 522 (77.2) | 1,303 (76.8) | ||
| Female | 725 (24.4) | 155 (22.6) | 570 (25.0) | 548 (23.1) | 154 (22.8) | 394 (23.2) | ||
| ASA | 0.476 | 0.894 | ||||||
| I | 131 (4.4) | 32 (4.7) | 99 (4.3) | 111 (4.7) | 30 (4.4) | 81 (4.8) | ||
| II | 2,468 (83.2) | 579 (84.3) | 1,889 (82.9) | 1,988 (83.8) | 570 (84.3) | 1,418 (83.6) | ||
| III | 367 (12.4) | 76 (11.1) | 291 (12.7) | 274 (11.5) | 76 (11.2) | 198 (11.7) | ||
| Resection extent | 0.004 | 0.310 | ||||||
| Proximal | 261 (8.8) | 40 (5.8) | 221 (9.7) | 154 (6.5) | 39 (5.8) | 115 (6.8) | ||
| Distal | 1,231 (41.5) | 305 (44.5) | 926 (40.6) | 989 (41.7) | 297 (43.9) | 692 (40.8) | ||
| Total | 1,474 (49.7) | 342 (49.8) | 1,132 (49.7) | 1,230 (51.8) | 340 (50.3) | 890 (52.4) | ||
| Digestive tract reconstruction | ||||||||
| Billroth I | 346 (11.7) | 52 (7.6) | 294 (12.9) | <0.001 | 196 (8.3) | 52 (7.7) | 144 (8.5) | 0.276 |
| Billroth II | 882 (29.7) | 251 (36.5) | 631 (27.7) | 789 (33.2) | 244 (36.1) | 545 (32.1) | ||
| Roux-en-Y | 1,479 (49.9) | 343 (49.9) | 1,136 (49.8) | 1,234 (52.0) | 341 (50.4) | 893 (52.6) | ||
| Esophagogastrostomy | 259 (8.7) | 41 (6.0) | 218 (9.6) | 154 (6.5) | 39 (5.8) | 115 (6.8) | ||
| Histological differentiation | <0.001 | 0.178 | ||||||
| Well/mod | 1,035 (34.9) | 277 (40.3) | 748 (32.8) | 896 (37.8) | 275 (40.7) | 621 (36.6) | ||
| Poor | 1,825 (61.5) | 383 (55.7) | 1,446 (63.4) | 1,394 (58.7) | 379 (56.1) | 1,015 (59.8) | ||
| Sig/muc | 106 (3.6) | 27 (3.9) | 85 (3.7) | 83 (3.5) | 22 (3.2) | 61 (3.6) | ||
| pT stage | <0.001 | 0.101 | ||||||
| T1 | 551 (18.6) | 151 (22.0) | 400 (17.6) | 467 (19.7) | 144 (21.3) | 323 (19.0) | ||
| T2 | 399 (13.5) | 112 (16.3) | 287 (12.6) | 338 (14.2) | 110 (16.3) | 228 (13.4) | ||
| T3 | 998 (33.6) | 234 (34.1) | 764 (33.5) | 847 (35.7) | 233 (34.5) | 614 (36.2) | ||
| T4a | 1,018 (34.3) | 190 (27.7) | 828 (36.3) | 721 (30.4) | 189 (28.0) | 532 (31.3) | ||
| pN stage | 0.003 | 0.724 | ||||||
| N0 | 1,042 (35.1) | 277 (40.3) | 765 (33.6) | 892 (37.6) | 269 (39.8) | 623 (36.7) | ||
| N1 | 518 (17.5) | 118 (17.2) | 400 (17.6) | 416 (17.5) | 116 (17.2) | 300 (17.1) | ||
| N2 | 541 (18.2) | 116 (16.9) | 428 (18.6) | 421 (17.7) | 116 (17.2) | 305 (18.0) | ||
| N3a | 518 (17.5) | 118 (17.2) | 400 (17.6) | 430 (18.1) | 118 (17.5) | 312 (18.4) | ||
| N3b | 347 (11.7) | 58 (8.4) | 289 (12.7) | 214 (9.0) | 57 (8.4) | 157 (9.3) | ||
| pTNM stage | 0.001 | 0.211 | ||||||
| I | 699 (23.6) | 191 (27.8) | 508 (22.3) | 598 (25.2) | 184 (27.2) | 414 (24.4) | ||
| II | 819 (27.6) | 203 (29.5) | 616 (27.0) | 687 (29.0) | 200 (29.6) | 487 (28.7) | ||
| III | 1,448 (48.8) | 293 (42.6) | 1,155 (50.7) | 1,088 (45.8) | 292 (43.2) | 796 (46.9) | ||
| BMI (kg/m2) (mean±SD) | 22.3±3.2 | 22.4±3.3 | 22.3±3.2 | 0.473 | 22.4±3.2 | 22.4±3.3 | 22.4±3.2 | 0.787 |
| Tumor size (cm) | 4.4±2.5 | 4.2±2.6 | 4.4±2.5 | 0.011 | 4.3±2.4 | 4.2±2.7 | 4.3±2.3 | 0.286 |
| Postoperative hospital stay (days) (mean±SD) | 8.1±4.0 | 8.0±3.5 | 8.1±4.1 | 0.599 | 8.1±4.0 | 8.0±3.5 | 8.1±4.2 | 0.522 |
| Operation time (min) | 206.2±68.3 | 266.1±69.7 | 188.2±56.5 | <0.001 | 211.3±70.3 | 266.2±70.2 | 189.4±57.1 | <0.001 |
| Number of retrieved lymph (mean±SD) | 27.0±8.9 | 24.8±7.0 | 27.6±9.3 | <0.001 | 26.7±8.6 | 24.8±7.0 | 27.4±9.1 | <0.001 |
| Estimate blood loss (mL) | 200.9±161.6 | 180.6±171.3 | 207.0±158.1 | <0.001 | 199.7±152.9 | 180.8±172.0 | 205.9±144.0 | <0.001 |
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; T, tumor; N, node; M, metastasis; TNM, tumor node metastases; SD, standard deviation; Well/mod, well/moderately differentiated.
Figure 1Research process.
Complications of the Two Groups
| LG | OG | Statistic | P-value | |
|---|---|---|---|---|
| n=676 (28.5) | n=1,697 (71.5) | |||
| Overall complication | χ2=9.122 | 0.003 | ||
| Yes | 104 (15.4) | 353 (20.8) | ||
| No | 572 (4.6) | 1,344 (79.2) | ||
| Severe complications | χ2=0.003 | 0.952 | ||
| Yes | 39 (5.8) | 99 (5.8) | ||
| No | 637 (94.2) | 1,598 (94.2) |
Postoperative Complications Assessed by Clavien–Dindo Classification System
| Variables | LG Group, n (%) | OG Group, n (%) | |
|---|---|---|---|
| ≤Ⅱ | 55 (8.1) | 254 (15.0) | |
| Fever (>38°C) | 2 (0.3) | 8 (0.5) | 0.807 |
| Nausea and vomiting | 0 (0) | 3 (0.2) | 0.650 |
| Transient hepatic function damage | 1 (0.1) | 4 (0.2) | 1.000 |
| Wound complications | 9 (1.3) | 51 (3.0) | |
| Intra-abdominal infection | 3 (0.4) | 13 (0.8) | 0.557 |
| Pneumonia | 13 (1.9) | 91 (5.4) | |
| Anemia | 14 (2.1) | 36 (2.1) | 0.939 |
| Pleural effusion | 3 (0.4) | 9 (0.5) | 1.000 |
| Anastomosis bleeding | 1 (0.1) | 3 (0.2) | 1.000 |
| Bowel obstruction | 1 (0.1) | 9 (0.5) | 0.344 |
| Hypoproteinemia | 2 (0.3) | 8 (0.5) | 0.807 |
| Leakage of lymphatics | 3 (0.4) | 8 (0.5) | 1.000 |
| Anastomosis stenosis | 1 (0.1) | 2 (0.1) | 1.000 |
| Intra-abdominal bleeding | 1 (0.1) | 2(0.1) | 1.000 |
| Retention of urine | 0 (0) | 1 (0.1) | 1.000 |
| Intraperitoneal effusion | 1 (0.1) | 6 (0.4) | 0.679 |
| шa | 23 (3.4) | 48 (2.8) | 0.411 |
| Pleural effusion | 6 (0.9) | 11 (0.6) | 0.723 |
| Intra-abdominal bleeding | 2 (0.3) | 4 (0.2) | 1.000 |
| Wound complications | 6 (0.9) | 12 (0.7) | 0.647 |
| Intraperitoneal effusion | 3 (0.4) | 4 (0.2) | 0.671 |
| Anastomosis leakage | 1 (0.1) | 5 (0.3) | 0.850 |
| Anastomosis bleeding | 2 (0.3) | 5 (0.3) | 1.000 |
| Intra-abdominal infection | 3 (0.4) | 7 (0.4) | 1.000 |
| шb | 15 (2.2) | 41 (2.4) | 0.775 |
| Wound problem | 1 (0.1) | 11 (0.6) | 0.219 |
| Intra-abdominal infection | 0 (0) | 6 (0.4) | 0.273 |
| Anastomosis bleeding | 2 (0.3) | 5 (0.3) | 1.000 |
| Intra-abdominal bleeding | 1 (0.1) | 4 (0.2) | 1.000 |
| Intestinal obstruction | 5 (0.7) | 10 (0.6) | 0.898 |
| Pancreatitis | 3 (0.4) | 1 (0.1) | 0.131 |
| Deep venous thrombosis | 1 (0.1) | 0 (0) | 0.634 |
| Anastomotic fistula | 2 (0.3) | 4 (0.2) | 1.000 |
| Ⅳa | 0 (0) | 8 (0.5) | 0.163 |
| Heart failure | 0 (0) | 3 (0.2) | 0.650 |
| Lung failure | 0 (0) | 4 (0.2) | 0.478 |
| Renal failure | 0 (0) | 1 (0.1) | 1.000 |
| IVb | 1 (0.1) | 1 (0.1) | 1.000 |
| Multiple organ failure | 1 (0.1) | 1 (0.1) | 1.000 |
| V (Death) | 0 (0) | 2 (0.1) | 0.913 |
Subgroup Analysis of Overall Complications
| Subgroup | OG | LG | OR | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|
| Total | Rate (%) | Total | Rate (%) | Lower | Upper | |||
| Male | 1,303 | 20.9 | 522 | 15.7 | 0.706 | 0.539 | 0.926 | 0.012 |
| Female | 394 | 20.6 | 154 | 14.3 | 0.644 | 0.385 | 1.067 | 0.091 |
| <60 | 927 | 18.3 | 373 | 13.3 | 0.705 | 0.502 | 0.990 | 0.043 |
| ≥60 | 770 | 23.8 | 303 | 17.5 | 0.680 | 0.484 | 0.955 | 0.026 |
| ASA<ш | 1,499 | 20.0 | 600 | 14.3 | 0.669 | 0.515 | 0.868 | 0.002 |
| ASA≥ш | 198 | 26.8 | 76 | 23.7 | 0.849 | 0.459 | 1.571 | 0.602 |
| TNM I | 414 | 14.5 | 184 | 10.9 | 0.720 | 0.420 | 1.233 | 0.230 |
| TNM II | 487 | 21.8 | 200 | 16.5 | 0.710 | 0.462 | 1.093 | 0.119 |
| TNM III | 796 | 23.5 | 292 | 17.5 | 0.689 | 0.489 | 0.972 | 0.033 |
| BMI<24 kg/m2 | 1,190 | 20.8 | 475 | 14.1 | 0.624 | 0.465 | 0.837 | 0.002 |
| BMI≥24 kg/m2 | 507 | 20.7 | 201 | 18.4 | 0.864 | 0.570 | 1.310 | 0.490 |
| Proximal gastrectomy | 115 | 24.3 | 39 | 10.3 | 0.355 | 0.116 | 1.087 | 0.061 |
| Distal gastrectomy | 692 | 15.5 | 297 | 13.8 | 0.876 | 0.594 | 1.292 | 0.503 |
| Total gastrectomy | 890 | 20.8 | 340 | 15.4 | 0.647 | 0.470 | 0.891 | 0.007 |
| Well–moderate differentiation | 621 | 21.7 | 275 | 18.2 | 0.800 | 0.558 | 1.148 | 0.255 |
| Poor differentiation, Signet ring cell or Mucinous | 1,076 | 20.3 | 401 | 13.5 | 0.612 | 0.443 | 0.846 | 0.003 |
| Tumor size (<5 cm) | 1,060 | 18.4 | 441 | 16.1 | 0.851 | 0.632 | 1.146 | 0.298 |
| Tumor size (≥5 cm) | 637 | 24.8 | 235 | 14.0 | 0.495 | 0.329 | 0.746 | 0.001 |
| Operation time<180 min | 831 | 17.1 | 44 | 13.6 | 0.766 | 0.318 | 1.847 | 0.552 |
| Operation time≥180 min | 866 | 24.4 | 632 | 15.5 | 0.570 | 0.437 | 0.743 | <0.01 |
Subgroup Analysis of Severe Complications
| Subgroup | OG | LG | OR | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|
| Total | Rate (%) | Total | Rate (%) | Lower | Upper | |||
| Male | 1,303 | 6.3 | 522 | 5.6 | 0.876 | 0.566 | 1.355 | 0.551 |
| Female | 394 | 4.3 | 154 | 6.5 | 1.540 | 0.689 | 3.442 | 0.289 |
| <60 | 927 | 5.2 | 373 | 3.8 | 0.714 | 0.389 | 1.312 | 0.276 |
| ≥60 | 770 | 6.6 | 303 | 8.3 | 1.268 | 0.770 | 2.086 | 0.350 |
| ASA<ш | 1,499 | 5.7 | 600 | 5.5 | 0.968 | 0.640 | 1.464 | 0.878 |
| ASA ш | 198 | 5.8 | 76 | 5.8 | 1.127 | 0.416 | 3.048 | 0.814 |
| TNM I | 414 | 3.9 | 184 | 3.8 | 0.984 | 0.398 | 2.433 | 0.972 |
| TNM II | 487 | 6.0 | 200 | 4.5 | 0.744 | 0.346 | 1.602 | 0.449 |
| TNM III | 796 | 6.8 | 292 | 7.9 | 1.175 | 0.707 | 1.952 | 0.533 |
| BMI<24 kg/m2 | 1,190 | 6.3 | 475 | 6.3 | 1.063 | 0.684 | 1.651 | 0.787 |
| BMI≥24 kg/m2 | 507 | 5.5 | 201 | 4.5 | 0.802 | 0.371 | 1.731 | 0.573 |
| Proximal gastrectomy | 115 | 6.1 | 39 | 2.6 | 0.406 | 0.048 | 3.409 | 0.392 |
| Distal gastrectomy | 692 | 3.3 | 297 | 5.1 | 1.547 | 0.796 | 3.009 | 0.195 |
| Total gastrectomy | 890 | 7.8 | 340 | 6.8 | 0.863 | 0.529 | 1.408 | 0.556 |
| Well–moderate differentiation | 621 | 6.1 | 275 | 7.6 | 1.268 | 0.730 | 2.205 | 0.398 |
| Poor differentiation, Signet ring cell or Mucinous | 1,076 | 5.7 | 401 | 4.5 | 0.782 | 0.456 | 1.340 | 0.370 |
| Tumor size (<5 cm) | 1,060 | 5.0 | 441 | 5.2 | 1.045 | 0.633 | 1.728 | 0.862 |
| Tumor size (≥5 cm) | 637 | 7.2 | 235 | 6.8 | 0.939 | 0.521 | 1.693 | 0.833 |
| Operation time<180 min | 831 | 4.2 | 44 | 4.5 | 1.083 | 0.252 | 4.656 | 0.951 |
| Operation time≥180 min | 866 | 7.8 | 632 | 5.9 | 0.779 | 0.513 | 1.184 | 0.242 |
Univariate and Multivariate Analyses of Postoperative Complications After Radical Gastrectomy
| Variables | Overall Complications | Severe Complications | ||||||
|---|---|---|---|---|---|---|---|---|
| Percent (%) | Uni- | Multi-OR (95% CI) | Multi- | Percent (%) | Uni- | Multi-OR (95% CI) | Multi- | |
| Age (years) | ||||||||
| <60 | 17.0 | 1.000 | 4.8 | 1.000 | ||||
| ≥60 | 22.0 | 1.269 (1.027–1.568) | 7.1 | 1.449 (1.022–2.052) | ||||
| ASA | 0.264 | |||||||
| <ш | 18.4 | 1.000 | 5.6 | |||||
| ≥ш | 25.9 | 1.457 (1.077–1.971) | 7.3 | |||||
| Resection extent | ||||||||
| Subtotal gastrectomy | 15.7 | 1.000 | 4.0 | 1.000 | ||||
| Total gastrectomy | 22.5 | 1.292 (1.040–1.606) | 7.5 | 1.556 (1.068–2.266) | ||||
| Estimate blood loss | ||||||||
| <200 mL | 14.8 | 1.000 | 4.1 | 1.000 | ||||
| ≥200 mL | 24.6 | 1.730 (1.402–2.135) | 7.8 | 1.784 (1.248–2.551) | ||||
| p T stage | ||||||||
| T1 | 11.6 | 1.000 | 2.8 | 1.000 | ||||
| T2–4a | 21.1 | 1.765 (1.288–2.418) | 6.6 | 1.950 (1.075–3.537) | ||||
| p N stage | 0.212 | |||||||
| N0 | 16.6 | 5.0 | ||||||
| N1–3 | 20.9 | 6.3 | ||||||
| Tumor size | ||||||||
| <5 cm | 17.7 | 5.1 | ||||||
| ≥5 cm | 21.9 | 7.1 | ||||||
| Operation time | ||||||||
| <180 min | 16.9 | 4.2 | ||||||
| ≥180 min | 20.6 | 6.7 | ||||||
| Operation method | 0.952 | |||||||
| LG | 20.8 | 5.8 | ||||||
| OG | 15.4 | 5.8 | ||||||
| Gender | 0.754 | 0.311 | ||||||
| Male | 19.4 | 6.1 | ||||||
| Female | 18.8 | 4.9 | ||||||
| Histological differentiation | 0.181 | 0.212 | ||||||
| Well–Moderate differentiation | 20.6 | 6.6 | ||||||
| Poor differentiation, Signet ring cell or Mucinous | 18.4 | 5.3 | ||||||
| BMI | 0.520 | 0.424 | ||||||
| <24 kg/m2 | 18.9 | 6.1 | ||||||
| ≥24 kg/m2 | 20.1 | 5.2 | ||||||
| Number of retrieved | 0.336 | 0.740 | ||||||
| <25 | 18.5 | 6.0 | ||||||
| ≥25 | 20.0 | 5.7 | ||||||
| Number of retrieved lymph | 0.153 | 0.754 | ||||||
Note: P-values less than 0.05 are highlighted in bold.
Abbreviations: Uni, univariate logistic regression analysis; Multi, multivariate logistic regression analysis; OR, odd ratio; CI, confidence interval.